Skip to main content
Erschienen in:

13.11.2021 | Case Report

Cervical spine tenosynovial giant cell tumor involving the atlantoaxial joint in a pediatric patient with medulloblastoma

verfasst von: Waylon Wai Chung Tsui, Kin Fen Kevin Fung, Pui Kwan Joyce Chan, Ming Keung Ernest Yuen, Yee Ling Elaine Kan

Erschienen in: Skeletal Radiology | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Tenosynovial giant cell tumor (TGCT) is a benign condition that arises from tendon sheaths, synovium, or bursae and is classified according to the site of involvement (intra-articular versus extra-articular) and pattern of growth (localized versus diffuse). The diffuse form tends to present as peri-articular masses and are locally aggressive. It usually presents as a mono-articular process affecting larger joints. Spinal involvement is extremely rare, particularly the cervical spine. In this case report, we present a pediatric case of spinal TGCT involving the C1-C2 joint which was incidentally detected in a 13-year-old girl undergoing surveillance for medulloblastoma recurrence. Although spinal TGCT is a benign condition, it remains a diagnostic challenge, which specific to our case can raise the concern for malignancy or metastasis. We also described a percutaneous biopsy approach using a spring-loaded blunt tip coaxial needle to avoid inadvertent vascular injury. The imaging features of spinal TGCT and biopsy approach for atlantoaxial lesion are discussed together with a comprehensive review of the literature.
Literatur
1.
Zurück zum Zitat Parmar HA, Sitoh YY, Tan KK, Teo J, Ibet SM, Hui F. MR imaging features of pigmented villonodular synovitis of the cervical spine. Am J Neuroradiol. 2004;25(1):145–9. Parmar HA, Sitoh YY, Tan KK, Teo J, Ibet SM, Hui F. MR imaging features of pigmented villonodular synovitis of the cervical spine. Am J Neuroradiol. 2004;25(1):145–9.
2.
Zurück zum Zitat Cazzato RL, Garnon J, Shaygi B, Caudrelier J, Bauones S, Tsoumakidou G, Koch G, Gangi A. Performance of a new blunt-tip coaxial needle for percutaneous biopsy and drainage of “hard-to-reach” targets. Cardiovasc Intervent Radiol. 2017;40(9):1431–9.CrossRefPubMed Cazzato RL, Garnon J, Shaygi B, Caudrelier J, Bauones S, Tsoumakidou G, Koch G, Gangi A. Performance of a new blunt-tip coaxial needle for percutaneous biopsy and drainage of “hard-to-reach” targets. Cardiovasc Intervent Radiol. 2017;40(9):1431–9.CrossRefPubMed
3.
Zurück zum Zitat Jaffe HL, Lichtenstein L, Sutro CJ. Pigmented villonodular synovitis, bursitis and tenosynovitis. Arch Pathol. 1941;31:731–65. Jaffe HL, Lichtenstein L, Sutro CJ. Pigmented villonodular synovitis, bursitis and tenosynovitis. Arch Pathol. 1941;31:731–65.
4.
Zurück zum Zitat WHO Classification of Tumours Editorial Board, Who Classification of Tumours Soft Tissue and Bone Tumours. 5th Edition, 2020. WHO Classification of Tumours Editorial Board, Who Classification of Tumours Soft Tissue and Bone Tumours. 5th Edition, 2020.
5.
Zurück zum Zitat Garner HW, Ortiguera CJ, Nakhleh RE. Pigmented villonodular synovitis. Radiographics. 2008;28(5):1519–23.CrossRefPubMed Garner HW, Ortiguera CJ, Nakhleh RE. Pigmented villonodular synovitis. Radiographics. 2008;28(5):1519–23.CrossRefPubMed
6.
Zurück zum Zitat Ohjimi Y, Iwasaki H, Ishiguro M, et al. Short arm of chromosome 1 aberration recurrently found in pigmented villonodular synovitis. Cancer Genet Cytogenet. 1996;90(1):80–5.CrossRefPubMed Ohjimi Y, Iwasaki H, Ishiguro M, et al. Short arm of chromosome 1 aberration recurrently found in pigmented villonodular synovitis. Cancer Genet Cytogenet. 1996;90(1):80–5.CrossRefPubMed
7.
Zurück zum Zitat Arnold PM, Dunlay RP, Haynes NG, Tawfik O, Hodges J. Pigmented villonodular synovitis of the thoracic spine: case report and review of the literature. Coluna/Columna. 2009;8(1):99–102.CrossRef Arnold PM, Dunlay RP, Haynes NG, Tawfik O, Hodges J. Pigmented villonodular synovitis of the thoracic spine: case report and review of the literature. Coluna/Columna. 2009;8(1):99–102.CrossRef
8.
Zurück zum Zitat Murphey MD, Rhee JH, Lewis RB, Fanburg-Smith JC, Flemming DJ, Walker EA. Pigmented villonodular synovitis: radiologic-pathologic correlation. Radiographics. 2008;28(5):1493–518.CrossRefPubMed Murphey MD, Rhee JH, Lewis RB, Fanburg-Smith JC, Flemming DJ, Walker EA. Pigmented villonodular synovitis: radiologic-pathologic correlation. Radiographics. 2008;28(5):1493–518.CrossRefPubMed
9.
Zurück zum Zitat Motamedi K, Murphey MD, Fetsch JF, et al. Villonodular synovitis (PVNS) of the spine. Skeletal Radiol. 2005;34:185–95.CrossRefPubMed Motamedi K, Murphey MD, Fetsch JF, et al. Villonodular synovitis (PVNS) of the spine. Skeletal Radiol. 2005;34:185–95.CrossRefPubMed
10.
Zurück zum Zitat Yamada S, Oshima K, Hamada K, et al. Giant cell tumor of the tendon sheath arising from a membrane surrounding the posterior arch of C1: a case report. Spine J. 2016;16:e353–7.CrossRefPubMed Yamada S, Oshima K, Hamada K, et al. Giant cell tumor of the tendon sheath arising from a membrane surrounding the posterior arch of C1: a case report. Spine J. 2016;16:e353–7.CrossRefPubMed
11.
Zurück zum Zitat Kleinman GM, Dagi TF, Poletti CE. Villonodular synovitis in the spinal canal: case report. J Neurosurg. 1980;52:846–8.CrossRefPubMed Kleinman GM, Dagi TF, Poletti CE. Villonodular synovitis in the spinal canal: case report. J Neurosurg. 1980;52:846–8.CrossRefPubMed
12.
Zurück zum Zitat Furlong MA, Motamedi K, Laskin WB, et al. Synovial-type giant cell tumors of the vertebral column: a clinicopathologic study of 15 cases, with a review of the literature and discussion of the differential diagnosis. Hum Pathol. 2003;34:670–9.CrossRefPubMed Furlong MA, Motamedi K, Laskin WB, et al. Synovial-type giant cell tumors of the vertebral column: a clinicopathologic study of 15 cases, with a review of the literature and discussion of the differential diagnosis. Hum Pathol. 2003;34:670–9.CrossRefPubMed
13.
Zurück zum Zitat Koontz NA, Quigley EP, Witt BL, Sanders RK, Shah LM. Pigmented villonodular synovitis of the cervical spine: case report and review of the literature. BJR Case Rep. 2016;2(1):20150264.PubMed Koontz NA, Quigley EP, Witt BL, Sanders RK, Shah LM. Pigmented villonodular synovitis of the cervical spine: case report and review of the literature. BJR Case Rep. 2016;2(1):20150264.PubMed
15.
Zurück zum Zitat Graham EJ, Kuklo TR, Kyriakos M, Rubin DA, Riew KD. Invasive pigmented villonodular synovitis of the atlantoaxial joint: a case report. J Bone Joint Surg Am 2002:84-A:1856–60. Graham EJ, Kuklo TR, Kyriakos M, Rubin DA, Riew KD. Invasive pigmented villonodular synovitis of the atlantoaxial joint: a case report. J Bone Joint Surg Am 2002:84-A:1856–60.
16.
Zurück zum Zitat Sharma H, Jane MJ, Reid R. Pigmented villonodular synovitis: diagnostic pitfalls and management strategy. Curr Orthop. 2005;19(3):215–22.CrossRef Sharma H, Jane MJ, Reid R. Pigmented villonodular synovitis: diagnostic pitfalls and management strategy. Curr Orthop. 2005;19(3):215–22.CrossRef
17.
Zurück zum Zitat Lavrador JP, Oliveira E, Gil N, Francisco AF, Livraghi S. C1-C2 pigmented villonodular synovitis and clear cell carcinoma: unexpected presentation of a rare disease and a review of the literature. Eur Spine J. 2015;24:S465–71. Lavrador JP, Oliveira E, Gil N, Francisco AF, Livraghi S. C1-C2 pigmented villonodular synovitis and clear cell carcinoma: unexpected presentation of a rare disease and a review of the literature. Eur Spine J. 2015;24:S465–71.
19.
Zurück zum Zitat Patil AA. Transoral stereotactic biopsy of the second cervical vertebral body: case report with technical note. Neurosurgery. 1989;25(6):999–1001; discussion 1001–2. Patil AA. Transoral stereotactic biopsy of the second cervical vertebral body: case report with technical note. Neurosurgery. 1989;25(6):999–1001; discussion 1001–2.
20.
22.
Zurück zum Zitat Wang K, Zhu B, Yang S, Liu Z, Yu M, Liu X. Primary diffuse type tenosynovial giant cell tumor of the spine: a report of 3 cases and systemic review of the literature. Turk Neurosurg. 2014;24:804–13.PubMed Wang K, Zhu B, Yang S, Liu Z, Yu M, Liu X. Primary diffuse type tenosynovial giant cell tumor of the spine: a report of 3 cases and systemic review of the literature. Turk Neurosurg. 2014;24:804–13.PubMed
23.
Zurück zum Zitat Benner B, Good L, Quiroga D, Schultz TE, Kassem M, Carson WE, Cherian MA, Sardesai S, Wesolowshi R. Pexidartinib, a novel small molecule CSF-1R inhibitor in use for tenosynovial giant cell tumor: a systematic review of pre-clinical and clinical development. Durg Des Devel Ther. 2020;14:1693–704.CrossRef Benner B, Good L, Quiroga D, Schultz TE, Kassem M, Carson WE, Cherian MA, Sardesai S, Wesolowshi R. Pexidartinib, a novel small molecule CSF-1R inhibitor in use for tenosynovial giant cell tumor: a systematic review of pre-clinical and clinical development. Durg Des Devel Ther. 2020;14:1693–704.CrossRef
24.
Zurück zum Zitat Tap W. ENLIVEN study: pexidartinib for tenosynovial giant cell tumor (TGCT). Future Oncol. 2020;16(25):1875–8.CrossRefPubMed Tap W. ENLIVEN study: pexidartinib for tenosynovial giant cell tumor (TGCT). Future Oncol. 2020;16(25):1875–8.CrossRefPubMed
25.
Zurück zum Zitat Pulitzer DR, Reed RJ. Localized pigmented villonodular synovitis of the vertebral column. Arch Pathol Lab Med. 1984;108(3):228–30.PubMed Pulitzer DR, Reed RJ. Localized pigmented villonodular synovitis of the vertebral column. Arch Pathol Lab Med. 1984;108(3):228–30.PubMed
26.
Zurück zum Zitat Finn MA, McCall TD, Schmidt MH. Pigmented villonodular synovitis associated with pathological fracture of the odontoid and atlantoaxial instability. Case Report Rev Lit J Neurosurg Spine. 2007;7:248–53. Finn MA, McCall TD, Schmidt MH. Pigmented villonodular synovitis associated with pathological fracture of the odontoid and atlantoaxial instability. Case Report Rev Lit J Neurosurg Spine. 2007;7:248–53.
27.
Zurück zum Zitat Blankenbaker DG, Tuite MJ, Koplin SA, Salamat MS, Hafez R. Tenosynovial giant cell tumor of the posterior arch of C1. Skeletal Radiol. 2008;37:667–71.CrossRefPubMed Blankenbaker DG, Tuite MJ, Koplin SA, Salamat MS, Hafez R. Tenosynovial giant cell tumor of the posterior arch of C1. Skeletal Radiol. 2008;37:667–71.CrossRefPubMed
28.
Zurück zum Zitat Teixeira WG, Lara NA Jr, Narazaki DK, et al. Giant-cell tumor of the tendon sheath in the upper cervical spine. J Clin Oncol. 2012;30:e250–3.CrossRefPubMed Teixeira WG, Lara NA Jr, Narazaki DK, et al. Giant-cell tumor of the tendon sheath in the upper cervical spine. J Clin Oncol. 2012;30:e250–3.CrossRefPubMed
29.
Zurück zum Zitat Cassier PA, Gelderblom H, Stacchiotti S, et al. Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis. Cancer. 2012;118:1649–55.CrossRefPubMed Cassier PA, Gelderblom H, Stacchiotti S, et al. Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis. Cancer. 2012;118:1649–55.CrossRefPubMed
Metadaten
Titel
Cervical spine tenosynovial giant cell tumor involving the atlantoaxial joint in a pediatric patient with medulloblastoma
verfasst von
Waylon Wai Chung Tsui
Kin Fen Kevin Fung
Pui Kwan Joyce Chan
Ming Keung Ernest Yuen
Yee Ling Elaine Kan
Publikationsdatum
13.11.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Skeletal Radiology / Ausgabe 6/2022
Print ISSN: 0364-2348
Elektronische ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-021-03952-z

Neu im Fachgebiet Radiologie

Ringen um den richtigen Umgang mit Zufallsbefunden

Wenn 2026 in Deutschland das Lungenkrebsscreening mittels Low-Dose-Computertomografie (LDCT) eingeführt wird, wird es auch viele Zufallsbefunde ans Licht bringen. Das birgt Chancen und Risiken.

Bald 5% der Krebserkrankungen durch CT verursacht

Die jährlich rund 93 Millionen CTs in den USA könnten künftig zu über 100.000 zusätzlichen Krebserkrankungen führen, geht aus einer Modellrechnung hervor. Damit würde eine von 20 Krebserkrankungen auf die ionisierende Strahlung bei CT-Untersuchungen zurückgehen.

Röntgen-Thorax oder LDCT fürs Lungenscreening nach HNSCC?

Personen, die an einem Plattenepithelkarzinom im Kopf-Hals-Bereich erkrankt sind, haben ein erhöhtes Risiko für Metastasen oder zweite Primärmalignome der Lunge. Eine Studie hat untersucht, wie die radiologische Überwachung aussehen sollte.

Statine: Was der G-BA-Beschluss für Praxen bedeutet

Nach dem G-BA-Beschluss zur erweiterten Verordnungsfähigkeit von Lipidsenkern rechnet die DEGAM mit 200 bis 300 neuen Dauerpatienten pro Praxis. Im Interview erläutert Präsidiumsmitglied Erika Baum, wie Hausärztinnen und Hausärzte am besten vorgehen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.